Health Care & Life Sciences » Pharmaceuticals | Instituto Rosenbusch

Instituto Rosenbusch S.A. | Cash Flow

Fiscal year is January-December. All values ARS Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
8,229.40
9,871.80
2,375.80
20,141.30
3,341.50
3,206.50
Depreciation, Depletion & Amortization
1,863.20
4,090.70
981.70
2,673.00
2,453.70
5,202
Other Funds
-
722.20
-
-
-
1,696.40
Funds from Operations
6,551.50
13,787.20
8,598.40
24,339.20
6,521.50
9,644.90
Changes in Working Capital
791.80
4,572.00
17,428.50
8,499.40
15,556.00
31,703
Net Operating Cash Flow
7,343.30
9,215.20
8,830.10
15,839.80
9,034.60
22,058.20
Capital Expenditures
4,293.00
4,197.40
2,452.50
15,756.60
1,952.80
Purchase/Sale of Investments
5,105.40
1.70
1.40
2.70
1.80
Net Investing Cash Flow
812.40
4,199.10
2,453.90
15,753.80
1,954.60
Issuance/Reduction of Debt, Net
1,947.90
2,970.30
13,753.10
1,459.20
10,170.40
Net Financing Cash Flow
1,947.90
2,248.10
13,753.10
1,459.20
10,170.40
Net Change in Cash
4,583.00
2,768.00
2,469.10
1,373.30
818.70
Free Cash Flow
11,550.10
5,043.70
11,247.40
83.20
10,987.40

About Instituto Rosenbusch

View Profile
Address
HipĆ³lito Yrigoyen 1628
Buenos Aires Buenos Aires 1089
Argentina
Employees -
Website http://www.rosenbusch.com
Updated 07/08/2019
Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. It operates through the following business segments: Biological Products, Pharmaceutical Products, and Others. The Biological Products segment includes products for reproductive-respiratory complex, brucellosis and carbuncle, clostridial and other vaccines, horses, pneumonia and calve diarrhea, and queratoconjuntivitis.